Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Chikungunya virus vaccine - Bharat Biotech

Next Previous
Drug Profile

Chikungunya virus vaccine - Bharat Biotech

Alternative Names: BBV 87; Inactivated Chikungunya virus vaccine - Bharat Biotech

Latest Information Update: 07 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bharat Biotech
  • Developer Bharat Biotech; International Vaccine Institute
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Chikungunya virus infections

Most Recent Events

  • 07 Jul 2025 Bharat Biotech terminates the Phase-II/III IVICHIK001 clinical trials in Chikungunya virus infections (Prevention) in Colombia, Costa Rica, Panama, Thailand, Guatemala (IM) due to discontinuation of the study for Part C. (NCT04566484)
  • 28 Jul 2022 No recent reports of development identified for phase-I development in Chikungunya-virus-infections(Prevention) in India (IM)
  • 01 Aug 2021 Phase-II/III clinical trials in Chikungunya virus infections (Prevention) in Panama, Costa Rica, Colombia (IM) (NCT04566484)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top